Author:
Carlsson J,Nordgren H,Sjöström J,Wester K,Villman K,Bengtsson N O,Ostenstad B,Lundqvist H,Blomqvist C
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Adams GP, Schier R, McCall AM, Simmons HH, Horak EM, Alpaugh RK, Marks JD, Weiner LM (2001) High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res 61: 4750–4755
2. Ahmed NU, Ueda M, Ichihashi M (1997) Increased level of c-erbB-2/neu/HER-2 protein in cutaneous squamous cell carcinoma. Br J Dermatol 136: 908–912
3. Andersson J, Linderholm B, Greim G, Lindh B, Lindman H, Tennvall J, Tennvall-Nittby L, Pettersson-Skold D, Sverrisdottir A, Soderberg M, Klaar S, Bergh J (2002) A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin) on a named patient basis in Sweden. Acta Oncol 41: 276–281
4. Bertram JS (2000) The molecular biology of cancer. Mol Aspects Med 21: 167–223
5. Bilous M, Dowsett M, Hanna W, Isola J, Lebeau A, Moreno A, Penault-Llorca F, Rüschoff J, Tomasic G, van de Vijver M (2003) Current perspectives on HER2 testing: a review of National Testing Guidelines. Mod Pathol 16: 173–182
Cited by
195 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献